Sabin Vaccine Institute
The Manager, CMC Drug Substance provides technical leadership and expertise across Chemistry, Manufacturing, and Controls (CMC) activities supporting vaccine drug substance development. This role focuses on process development, characterization, technology transfer, and GMP manufacturing, supporting programs from late-stage clinical development through process validation, regulatory licensure, and commercialization. The successful candidate will possess demonstrated experience leading technology transfers across process development and manufacturing environments, with hands-on knowledge of vaccine manufacturing operations and viral vaccine platforms.
Home: Sabin: Making Vaccines Accessible, Driving Innovation, Expanding Global Immunization Efforts Learn more.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sabin Vaccine Institute.
8% below the average for this role
Associate Scientific Fellow, Downstream Technology Transfer Lead, Drug Substance Operations, Biotherapeutics Process Development, Pharmaceutical Sciences
BioLife Plasma Services
Associate Director CMC Drug Substance
Celldex Therapeutics
Associate Principal Scientist/Associate Director, Engineering- Biologics Drug Substance Commercialization
MSD
Director, CMC Drug Substance
Olema Oncology
Senior Director, CMC Drug Substance Development & Manufacturing
Olema Oncology
Intern, CMC Drug Substance
Eikon Therapeutics